Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Genetics-driven risk predictions leveraging the Mendelian randomization framework

Genetics-driven Risk Predictions with Differentiable Mendelian Randomization

A Machine Learning Model for Disease Risk Prediction by Integrating Genetic and Non-Genetic Factors

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Practical implementation of frailty models in Mendelian risk prediction

The Application of Mendelian Randomization in Cardiovascular Disease Risk Prediction: Current Status and Future Prospects

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Deep Learning for Polygenic Risk Prediction

A Novel Method for Mendelian Randomization Analyses With Pleiotropy and Linkage Disequilibrium in Genetic Variants From Individual Data

Genetic drug target validation using Mendelian randomisation

Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization

A latent outcome variable approach for Mendelian randomization using the expectation maximization algorithm

Machine learning model to predict risk assessment of a child inheriting a genetic disorder

Improving genetic risk modeling of dementia from real-world data in underrepresented populations

Effective Genetic Risk Prediction Using Mixed Models

Likelihood-based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling

Causal mediation analysis for time-varying heritable risk factors with Mendelian Randomization

PRS-GRID: A Cross and Within Ancestry Polygenic Risk Prediction Method Based on Individual Genetic Distance

Bayesian network-based Mendelian randomization for variant prioritization and phenotypic causal inference

Mendelian randomisation with proxy exposures: challenges and opportunities

Predicting the status of human complex diseases with random forest and polygenic risk scores